Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis (RA) is a debilitating chronic systemic autoimmune inflammatory disease, a long term condition and affects 1-3% of population worldwide tha t causes severe pain, inflamed bone erosion, unsteadiness, stiffness in the joints and deformity.It gradually deteriorates over the course of many years.The exact causes of RA are still unknown but genes, environmental factor, hormone, obesity, smoking; age may be involved in autoimmune development and progression.Pathophysiology of RA is usually due to synovial membrane inflammation, chemokine involvement leading to swollen joints.In the early hours, diagnosis and management can help to prevent damage to the joints.To understand the recent advances in physiology of RA, several biologics DMARDS include TNF-inhibitor, anti-CD20 antibody, IL-6 receptor antibody are implemented in current therapies and these advances are based on disease modifying therapy that includes with a goal where drug should reach targeted site and focused on pain relieving.Therapies are normally personalized with patients need including their general well-being.This review provides a modern appraisal from current literature on different RA treatment regimes.
No takes yet. Share an insight, caveat, or question.
Das et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: